Diphenylhydantoin in the Prevention of Recurring Ventricular Tachycardia

The efficacy of diphenylhydantoin in preventing recurrent ventricular tachycardia was studied in ten patients, nine of whom had documented coronary heart disease. Prolonged continuous ECG monitoring of up to 72 hr was performed in each case. Oral and intravenous loading doses of 1000 to 1500 mg were given on the first day of therapy to insure rapid attainment of therapeutic blood levels. Diphenylhydantoin was uniformly ineffective in preventing recurrence of ventricular tachycardia despite the presence of what is regarded as adequate therapeutic plasma concentrations (greater than 19.0 μg/ml in five patients, 10.8-18.0 μg/ml in the remaining five) shortly after onset of ventricular tachycardia. Nystagmus was noted in eight patients, but plasma diphenylhydantoin levels varied widely (8.6-35.0 μg/ml) when this sign of neurotoxicity was first detected.

• Publication year

  1971

• Venue

  Circulation

• Publication date

  1971-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.43.3.420PMID 5101744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of anticonvulsive drugs in the treatment of recurrent cardiac arrhythmias.

  2009cited by this paper
• 5, 5-Diphenylhydantoin (dilantin) blood levels after oral or intravenous dosage in man.

  2009cited by this paper
• Localization of A-V conduction defects in man by recording of the His bundle electrogram.

  1970cited by this paper
• The concept of precoronary care.

  1970cited by this paper
• Predisposing Factors in Sudden Cardiac Death in Tecumseh, Michigan: A Prospective Study

  1970cited by this paper
• Wenckebach and Mobitz Type II A‐V Block Due to Block Within the His Bundle and Bundle Branches

  1970cited by this paper
• [Diphenylhydantoin in cardiac arrhythmias].

  1970cited by this paper
• Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administration

  1969cited by this paper
• Diphenylhydantoin: pharmacological and clinical use.

  1969cited by this paper
• Coronary and precoronary care.

  1969cited by this paper
• The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men.

  1969cited by this paper
• The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.

  1969cited by this paper
• Treatment of cardiac arrhythmias with phenytoin

  1969cited by this paper
• Diphenylhydantoin in cardiac arrhythmias.

  1968cited by this paper
• Atrioventricular Block, Type II (Mobitz)—Its Nature and Clinical Significance

  1968cited by this paper
• Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

  1968cited by this paper
• Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients.

  1968cited by this paper
• Electrophysiological Effects of Direct Current Countershock before and after Ouabain Sensitization and after Diphenylhydantoin Desensitization in the Dog

  1968cited by this paper
• Intravenous diphenylhydantoin sodium (Dilantin) in cardiac arrhythmias.

  1967cited by this paper
• The coronary care unit. New perspectives and directions.

  1967cited by this paper
• The current status of diphenylhydantoin in heart disease.

  1967cited by this paper
• Epidemiological Study of Sudden and Unexpected Deaths due to Arteriosclerotic Heart Disease

  1966cited by this paper
• SODIUM DIPHENYLHYDANTOIN IN THE TREATMENT OF RECURRENT CARDIAC ARRHYTHMIAS.

  1965cited by this paper
• DIPHENYLHYDANTOIN SODIUM IN CARDIAC ARRHYTHMIAS.

  1965cited by this paper
• Electrical Activity During the P‐R Interval

  1960cited by this paper
• The effect of diphenylhydantoin (Dilantin) sodium on atrial flutter and fibrillation provoked by focal application of a conitine or delphinine.

  1960cited by this paper
• The use of diphenylhydantoin (dilantin) sodium in the treatment of ventricular tachycardia.

  1958cited by this paper
• Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man.

  1956cited by this paper
• Effectiveness of several antifibrillary drugs in the hypothermic dog.

  1955cited by this paper
• The Effects of Diphenylhydantoin Sodium, Glucose and β‐Diethylaminoethyl Diphenylpropylacetate Hydrochloride on Cyclopropane‐Epinephrine Arrhythmias in the Dog

  1955cited by this paper
• The Effect of Diphenylhydantoin Sodium (Dilantin), Procaine Hydrochloride, Procaine Amide Hydrochloride, and Quinidine Hydrochloride upon Ouabain‐Induced Ventricular Tachycardia in Unanesthetized Dogs

  1954cited by this paper
• The Dissection of the Atrioventricular Node Bundle and Bundle Branches in the Human Heart

  1951cited by this paper
• Persistent ventricular pacemaker following basal skull fracture; report of a case in a 5-year-old girl.

  1951cited by this paper
• Effects of diphenylhydantoin sodium (dilantin sodium) and phenobarbital sodium upon ectopic ventricular tachycardia in acute myocardial infarction.

  1950cited by this paper

• Adverse Effects of Antiarrhythmic Drugs

  2012cites this paper
• PREHOSPITAL CARE OF ACUTE MI the patient with acute myocardial infarction

  2005cites this paper
• Phenytoin in the Treatment of Inducible Ventricular Tachycardia: Results of Electrophysiologic Testing and Long‐Term FoUow‐Up

  1987cites this paper
• Review of hypertrophic cardiomyopathy.

  1987cites this paper
• Medical management of ischemic heart disease

  1983cites this paper
• Pharmacologic treatment of cardiac arrhythmias: 25 years of progress.

  1983cites this paper
• Clinical use of antiarrhythmic drugs

  1983cites this paper
• The Effects of Sodium Channel Inhibitors on Early Arrhythmias Associated with Acute Myocardial Ischaemia

  1982cites this paper
• Task force IV: pharmacologic interventions. Emergency cardiac care.

  1982cites this paper
• Task force IV: Pharmacologie interventions

  1982cites this paper
• Therapeutic Drug Monitoring of Antiarrhythmic Agents

  1982cites this paper
• Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.

  1981cites this paper
• A New Method for Evaluating Antiarrhythmic Drug Efficacy

  1980cites this paper
• Sudden cardiac death--management of the patient at risk.

  1980cites this paper
• Ethmozin, A New Antiarrhythmic Drug for Suppressing Ventricular Premature Complexes

  1980cites this paper
• Effects of Acebutolol on Chronic Stable Angina Pectoris: A Placebo‐controlled, Double‐blind, Randomized Crossover Study

  1980cites this paper
• Chronic ventricular arrhythmias: comparative drug effectiveness and toxicity.

  1980cites this paper
• Anti-arrhythmic drugs.

  1979cites this paper
• Management of cardiac arrhythmias occurring in myocardial infarction

  1979cites this paper
• Mexiletine: Use in Control of Chronic Drug-Resistant Ventricular Arrhythmia

  1979cites this paper
• Clinical pharmacology of antiarrhythmic agents.

  1979cites this paper
• Long-term oral antiarrhythmic therapy with mexiletine.

  1978cites this paper
• Long-term effect of perhexiline maleate on ventricular ectopic activity.

  1978cites this paper
• Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity

  1978cites this paper
• Conjugate Lateral Gaze Nystagmus and Free Phenytoin Concentrations in Plasma: Lack of Correlation

  1978cites this paper
• Antiarrhythmic Drugs: Clinical Pharmacology and Therapeutic Uses

  1978cites this paper
• Medical staff conference. The significance and treatment of long-term ventricular arrhythmias.

  1977cites this paper
• [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

  1977cites this paper
• Management of patients with malignant ventricular arrhythmias.

  1977cites this paper
• Plasmakonzentrationen nach Injektion und Infusion von Phenytoin

  1977cites this paper
• Side effects of antiarrhythmic drugs

  1977cites this paper
• Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.

  1976cites this paper
• Treatment of recurrent symptomatic ventricular tachycardia.

  1976cites this paper
• Successful resuscitation of two near simultaneous cases of cardiac arrest with a review of fifteen cases occurring during supervised exercise.

  1976cites this paper
• Clinical efficacy of amiodarone as an antiarrhythmic agent.

  1976cites this paper
• Long-term treatment of ventricular arrhythmias with oral mexiletine.

  1976cites this paper
• Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. B.

  1975cites this paper
• Pharmacologic therapy of ventricular arrhythmias.

  1975cites this paper
• Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.

  1975cites this paper
• Mexiletine.

  1975cites this paper
• Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations.

  1975cites this paper
• Tritiated digoxin metabolism after prior treatment with propranolol or diphenylhydantoin sodium.

  1975cites this paper
• Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. A.

  1975cites this paper
• Individualization of anticonvulsant therapy.

  1974cites this paper
• [Haemodynamic reactions to injection and subsequent infusion of phenytoin (author's transl)].

  1974cites this paper
• [Long-term treatment of arrhythmias].

  1974cites this paper
• Diphenylhydantoin as an antiarrhythmic drug.

  1974cites this paper
• The treatment of acute myocardial infarction.

  1974cites this paper
• Coronary Care: The Understanding and Treatment of Atrial and Ventricular Dysrhythmias

  1973cites this paper
• Long‐Term Use of Procaine Amide following Acute Myocardial Infarction

  1973cites this paper
• Immediate and Remote Prognostic Significance of Fascicular Block during Acute Myocardial Infarction

  1973cites this paper
• Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects.

  1973cites this paper
• Ventricular Tachyarrhythmias: Clinical Aspects

  1973cites this paper
• Tachyarrhythmias in Myocardial Infarction

  1972cites this paper
• Treatment of ventricular arrhythmias in ambulatory patients.

  1972cites this paper
• Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease.

  1972cites this paper
• Prehospital Care of Acute Myocardial Infarction

  1972cites this paper
• Approaches to Sudden Death from Coronary Heart Disease

  1971cites this paper